Benuvia is proud to announce Brazil’s National Health Surveillance Agency (ANVISA) has officially certified Benuvia for Good Manufacturing Practices (GMP). This certification enables Benuvia to manufacture and distribute non-sterile liquid pharmaceutical products in Brazil, the largest healthcare market in Latin America. Achieving ANVISA’s rigorous standards underscores our commitment to providing high-quality, compliant pharmaceutical manufacturing solutions tailored to Brazil’s rapidly growing healthcare sector. We look forward to partnering with both local and international pharmaceutical companies to bring life-changing therapies to patients in need. Read the press release here:? https://lnkd.in/eYBKRjJC (the link will be automatically shortened in Linkedin) #ANVISA? #GMP? #PharmaceuticalManufacturing #BrazilHealthcare #Benuvia #LifeChangingTherapies
Benuvia
制药业
Round Rock，Texas 2,185 位关注者
Controlled Substance Solutions. Specialty Pharmaceutical CDMO. Made in the USA.
关于我们
At Benuvia, we help clients navigate the complexities of the development and manufacture of controlled substances for novel therapies, offering complete control over the drug development process. As a specialized CDMO offering small molecule API and finished dose development and cGMP manufacturing services, we specialize in the formulation, synthesis, and production of highly regulated and complex compounds, delivering end-to-end solutions tailored to our clients’ needs. We provide the expertise, process optimization, scale-up capabilities, and infrastructure to accelerate time-to-market while also reducing costs. Benuvia is a pioneer in the development and manufacturing of controlled substances with over 15 years of experience in cannabinoids, psychedelics, and other highly regulated compounds. We are the go-to partner for companies seeking high-quality products, robust regulatory compliance, and a first-class customer experience. Benuvia has been at the forefront of cannabinoid innovation since 2009, manufacturing pharmaceutical-grade, cGMP pure cannabidiol (CBD). Our expertise extends to other highly controlled substances, allowing us to support therapies in emerging fields like psychedelics. From formulation to API synthesis and robust analytical development to manufacturing, packaging, serialized labeling, warehousing, import and export capabilities, and regulatory affairs, Benuvia offers a comprehensive suite of solutions to meet your clinical and commercial goals. Located near Austin, TX, in Round Rock, our 83,000-square-foot, purpose built, state-of-the-art facility is DEA and FDA registered and fully compliant with cGMP standards, as well as the DEA, EPA, and OSHA. These certifications, along with our proven track record in controlled substances, ensure the highest levels of quality, safety, and compliance for your products. Benuvia helps you navigate the unique challenges of controlled substances with tailored global solutions. Reach out today.
- 网站
-
https://www.benuvia.com
Benuvia的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Round Rock，Texas
- 类型
- 私人持股
- 创立
- 2020
- 领域
- Controlled Substances、Regulatory Services、Pharmaceutical Development 、API Manufacturing、Analytical Development、Analytical Testing、Liquid Fill、Psychedelics、Cannabinoids、D9THC、CBC和CBG
地点
-
主要
获取路线
3950 N Mays St
US，Texas，Round Rock，78665
Benuvia员工
动态
-
Benuvia is proud to announce Brazil’s National Health Surveillance Agency (ANVISA) has officially certified Benuvia for Good Manufacturing Practices (GMP). This certification enables Benuvia to manufacture and distribute non-sterile liquid pharmaceutical products in Brazil, the largest healthcare market in Latin America. Achieving ANVISA’s rigorous standards underscores our commitment to providing high-quality, compliant pharmaceutical manufacturing solutions tailored to Brazil’s rapidly growing healthcare sector. We look forward to partnering with both local and international pharmaceutical companies to bring life-changing therapies to patients in need. Read the press release here:? https://lnkd.in/eYBKRjJC (the link will be automatically shortened in Linkedin) #ANVISA? #GMP? #PharmaceuticalManufacturing #BrazilHealthcare #Benuvia #LifeChangingTherapies
-
Regulatory roadblocks slowing you down? What if you could cut approval timelines, reduce costs, and secure investor confidence—all while staying fully compliant? That’s exactly what Benuvia helped a biotech startup achieve. Faster IND/CTA approvals. Smoother regulatory pathways. Successful trial initiation. Want to know how? Download the case study now! https://lnkd.in/ejSWxcsT #IND #CTA #Benuvia #Pharma #Innovation
-
-
Let's start a conversation, I will be at DCAT! Matt Delaney, CBDO - [email protected]
Plan ahead for DCAT 2025! Benuvia will be available for meetings at the Intercontinental Hotel. Let's connect and discuss how our expertise can fuel your innovation. Schedule your meeting now to secure your preferred time: https://lnkd.in/eHbzFvZY #dcatweek #benuvia #DrugDevelopment
-
-
Plan ahead for DCAT 2025! Benuvia will be available for meetings at the Intercontinental Hotel. Let's connect and discuss how our expertise can fuel your innovation. Schedule your meeting now to secure your preferred time: https://lnkd.in/eHbzFvZY #dcatweek #benuvia #DrugDevelopment
-
-
If you are attending this great conference, be sure to stop by and visit with Benuvia experts to learn how our specialty CDMO services can help your journey to commercialization.
This Valentine's Day, we’re showing some love to the incredible exhibitors who've confirmed their spot on the World Orphan Drug Congress USA 2025 expo floor! ???? From AI to automation, gene therapies to patient advocacy, these innovators are transforming the future of?#raredisease treatment?and?#orphandrug development. AIXIAL GROUP | Avance Clinical | Benuvia | Definitive Healthcare | Genevoyager | Only Orphans Cote LLC | Onyx Scientific | Orsini - Rare Disease Pharmacy Solutions | Rare Disease Research, LLC | Sharp Sterile Manufacturing If your ? one true love ? is ??????????????-???????? ????????, ???????????????????????????? ????????????????, or ???????????????????? ???????? ???????????????? ??????????????, then World Orphan Drug Congress USA is the place to be??Lock in your spot below ? ?????????? ????% ?????? ??????????????????'?? ?????? ???????? ???????? ???? ????????????????! ?? Get in on the love and secure huge savings now with code LOVERARE ? https://lnkd.in/eaz-cxwZ Did you hear our expo floor is ???????????? ???????? ??????? Inquire today and claim your booth before it's too late ? https://lnkd.in/ev8pfujX #WorldOrphanUSA ??? April 22-24 ?? Boston Convention & Exhibition
-
How Regulatory Oversight Protects CBD Consumers Many consumers trust that a Certificate of Analysis (COA) guarantees product safety, but without strict regulatory oversight, that’s not always the case. Mislabeling, unverified testing, and misleading claims are widespread in the CBD market—particularly in medical cannabis, consumable hemp, and many other nutraceutical products, which lack the stringent oversight seen in pharmaceutical manufacturing. Consumer education and safety should always come first. Understanding the difference between pharmaceutical-grade products and loosely regulated alternatives is key to making informed decisions. At Benuvia, we operate under cGMP-compliant pharmaceutical standards, ensuring the highest levels of safety, consistency, and efficacy of all APIs and finished products we manufacture—but more importantly, we believe in raising industry awareness so that consumers can make informed choices. This white paper uncovers misleading marketing tactics, highlights the risks of unregulated CBD, and provides insights into what consumers and businesses should look for in a truly safe, high-quality, and consistent product. Download the white paper to learn more and help raise awareness about the need for higher standards in the CBD industry. #HealthCare #PatientExperience #CBD #Hemp #ConsumerSafety #Education #RegulatoryCompliance #HealthAndSafety #QualityAssurance #GMP #Benuvia
-
Couldn’t be more excited about the launch of our brand-new website, benuvia.com! ?? The updated design truly showcases Benuvia’s expertise and dedication to empowering our clients in their small molecule drug development journeys. #Benuvia #WebsiteLaunch #Innovation #DrugDevelopment
Ring in the New Year with the all-new Benuvia website at benuvia.com. In welcoming 2025, we are thrilled to unveil our revamped website, designed to reflect our identity and core strengths - empowering clients to navigate their small molecule drug development journey seamlessly. The updated site presents a streamlined, user-friendly interface that highlights Benuvia's expertise as a full-service CDMO specializing in small molecule API and liquid drug product, including extensive experience with cannabinoids, entheogens and other controlled substances. This redesign signifies more than just a visual upgrade; it embodies a renewed commitment to our clients - at Benuvia, it's all in your control. Whether you seek end-to-end API process development & manufacturing or regulatory support, you'll find everything you need to stay in control - right at your fingertips. Visit us today and let's make 2025 a year of breakthroughs together! #benuvia #controlledsubstances #API #smallmoleculeAPI
-
Ring in the New Year with the all-new Benuvia website at benuvia.com. In welcoming 2025, we are thrilled to unveil our revamped website, designed to reflect our identity and core strengths - empowering clients to navigate their small molecule drug development journey seamlessly. The updated site presents a streamlined, user-friendly interface that highlights Benuvia's expertise as a full-service CDMO specializing in small molecule API and liquid drug product, including extensive experience with cannabinoids, entheogens and other controlled substances. This redesign signifies more than just a visual upgrade; it embodies a renewed commitment to our clients - at Benuvia, it's all in your control. Whether you seek end-to-end API process development & manufacturing or regulatory support, you'll find everything you need to stay in control - right at your fingertips. Visit us today and let's make 2025 a year of breakthroughs together! #benuvia #controlledsubstances #API #smallmoleculeAPI